Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2016 - 2025)

Kazia Therapeutics (KZIA) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $178345.0 in Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability fell 85.51% year-over-year to $178345.0; the TTM figure through Dec 2025 stood at $178345.0 (down 85.51% YoY), while the FY2025 annual figure was $173960.2, down 86.92% from the prior year.
• Non-Current Deferred Tax Liability climbed to $178345.0 in Q4 2025, from $173960.2 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $2.3 million in Q2 2021 and bottomed at $173960.2 in Q2 2025.
• A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2021 — Non-Current Deferred Tax Liability gained 0.79% — and 2025, when it sank 86.92%.
• Year by year, Non-Current Deferred Tax Liability stood at $2.3 million in 2021, then retreated by 25.39% to $1.7 million in 2022, then retreated by 21.9% to $1.3 million in 2023, then slipped by 6.29% to $1.2 million in 2024, then plunged by 85.51% to $178345.0 in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $178345.0 (Q4 2025), $173960.2 (Q2 2025), and $1.2 million (Q4 2024), per Business Quant data.

Peer Comparison